Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
暂无分享,去创建一个
Gerald C. Chu | L. Chin | Yonghong Xiao | Wei Wang | R. DePinho | R. Weissleder | Hailei Zhang | L. Cantley | S. Hua | A. Hezel | Jian Hu | Eliot Fletcher-Sananikone | Y. A. Wang | G. Chu | J. Asara | J. Locasale | Carol S. Lim | J. Paik | B. Gan | J. L. Coloff | A. Kimmelman | A. Guimaraes | C. Lyssiotis | E. Martin | S. R. Perry | Hongwu Zheng | H. Ying | J. Son | Hai-yan Yan | Wei Wang | Shujuan Chen | A. Viale | Jeffery T. Chang | Samuel R. Perry | Alec C. Kimmelman | Jonathan L. Coloff | Lynda Chin | Ronald A. DePinho | Y. Alan Wang | Sujun Hua | Jaekyoung Son | Hailei Zhang | Haiyan Yan | Shujuan Chen | Andrea Viale | Hongwu Zheng | Ji-hye Paik | Carol Lim | A. Guimaraes | Eric S. Martin | Jeffery Chang | Jian Hu | Boyi Gan | Yonghong Xiao | Ralph Weissleder | Carol Lim
[1] J. Asara,et al. A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue , 2012, Nature Protocols.
[2] Gregory Stephanopoulos,et al. Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis , 2012, BMC Proceedings.
[3] Scott E. Kern,et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.
[4] A. Caudy,et al. Riboneogenesis in Yeast , 2011, Cell.
[5] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[6] F. McCormick,et al. Therapeutic strategies for targeting ras proteins. , 2011, Genes & cancer.
[7] A. Mancuso,et al. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase , 2011, Nature Cell Biology.
[8] E. Petricoin,et al. Proteomic analysis of pancreatic ductal adenocarcinoma cells reveals metabolic alterations. , 2011, Journal of proteome research.
[9] 이연수. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer , 2011 .
[10] H. Coller,et al. The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. , 2010, Genes & development.
[11] A. Levine,et al. The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes , 2010, Science.
[12] Gerald W. Hart,et al. Glycomics Hits the Big Time , 2010, Cell.
[13] Lin Cui,et al. &agr;-Smooth Muscle Actin Expressing Stroma Promotes an Aggressive Tumor Biology in Pancreatic Ductal Adenocarcinoma , 2010, Pancreas.
[14] Malte Buchholz,et al. Stromal biology and therapy in pancreatic cancer , 2010, Gut.
[15] W. Wheaton,et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.
[16] K. Kinzler,et al. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.
[17] J. Settleman,et al. Oncogenic K-ras “addiction” and synthetic lethality , 2009, Cell cycle.
[18] Patricia Greninger,et al. A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. , 2009, Cancer cell.
[19] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[20] C. Thompson,et al. The molecular determinants of de novo nucleotide biosynthesis in cancer cells. , 2009, Current opinion in genetics & development.
[21] Tsung-Cheng Chang,et al. c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.
[22] B. Seliger,et al. Altered detoxification status and increased resistance to oxidative stress by K-ras transformation. , 2008, Cancer research.
[23] Anthony Mancuso,et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.
[24] Gerald C. Chu,et al. P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation , 2008, Nature.
[25] G. Evan,et al. Modelling Myc inhibition as a cancer therapy , 2008, Nature.
[26] Ralph J Deberardinis,et al. Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.
[27] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[28] S. Henderson,et al. Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production , 2007, Proceedings of the National Academy of Sciences.
[29] R. DePinho,et al. Genetics and biology of pancreatic ductal adenocarcinoma. , 2006, Genes & development.
[30] M. Lerner,et al. [1,2-13C2]-D-Glucose Profiles of the Serum, Liver, Pancreas, and DMBA-Induced Pancreatic Tumors of Rats , 2005, Pancreas.
[31] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] Marta Cascante,et al. K-ras Codon-Specific Mutations Produce Distinctive Metabolic Phenotypes in Human Fibroblasts , 2005 .
[33] J. Esko,et al. The sweet and sour of cancer: glycans as novel therapeutic targets , 2005, Nature Reviews Cancer.
[34] J. Whitsett,et al. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction , 2005, Nucleic acids research.
[35] Marta Cascante,et al. K-ras codon-specific mutations produce distinctive metabolic phenotypes in NIH3T3 mice [corrected] fibroblasts. , 2005, Cancer research.
[36] J. Hecht,et al. Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[38] R. DePinho,et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.
[39] E. Petricoin,et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.
[40] Manuel Serrano,et al. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. , 2003, Cancer cell.
[41] Mitchell D Schnall,et al. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. , 2002, Cancer cell.
[42] C. Wright,et al. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors , 2002, Nature Genetics.
[43] H. Varmus,et al. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.
[44] T. Jacks,et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice , 2001, Nature.
[45] A. Berns,et al. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. , 2000, Genes & development.
[46] D. Felsher,et al. Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.
[47] L. Chin,et al. Essential role for oncogenic Ras in tumour maintenance , 1999, Nature.
[48] M. Cascante,et al. Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism? , 1998, Medical hypotheses.
[49] P. Paty,et al. Beta 1-6 branching of N-linked carbohydrate is associated with K-ras mutation in human colon carcinoma cell lines. , 1995, Biochemical and biophysical research communications.
[50] J. Russo,et al. Cell surface glycosylation changes accompanying immortalization and transformation of normal human mammary epithelial cells. , 1991, Cancer letters.
[51] J. Dennis,et al. Oncogenes conferring metastatic potential induce increased branching of Asn-linked oligosaccharides in rat2 fibroblasts. , 1989, Oncogene.
[52] J. Neefjes,et al. Ras (proto)oncogene induces N‐linked carbohydrate modification: temporal relationship with induction of invasive potential. , 1988, The EMBO journal.
[53] J. Williams,et al. The pentose pathway: a random harvest. Impediments which oppose acceptance of the classical (F-type) pentose cycle for liver, some neoplasms and photosynthetic tissue. The case for the L-type pentose pathway. , 1987, The International journal of biochemistry.
[54] E. Racker,et al. Glycolysis and methylaminoisobutyrate uptake in rat-1 cells transfected with ras or myc oncogenes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.